Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miranda G Greiner

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Substance Abuse Treatment|June 7, 2021
Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapseMiranda G Greiner, Matisyahu Shulman, Tse-Hwei Choo, et al.
Substance Use & Misuse|August 17, 2022
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable NaltrexoneMiranda G Greiner, Matisyahu Shulman, Jennifer Scodes, et al.
JAMA Network Open|May 8, 2024
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical TrialMatisyahu Shulman, Miranda G Greiner, Hiwot M Tafessu, et al.
Contemporary Clinical Trials|March 17, 2023
Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation studyMiranda G Greiner, Matisyahu Shulman, Onumara Opara, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Substance Abuse Treatment|June 7, 2021
Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapseMiranda G Greiner, Matisyahu Shulman, Tse-Hwei Choo, et al.
Substance Use & Misuse|August 17, 2022
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable NaltrexoneMiranda G Greiner, Matisyahu Shulman, Jennifer Scodes, et al.
JAMA Network Open|May 8, 2024
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical TrialMatisyahu Shulman, Miranda G Greiner, Hiwot M Tafessu, et al.
Contemporary Clinical Trials|March 17, 2023
Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation studyMiranda G Greiner, Matisyahu Shulman, Onumara Opara, et al.
Pageof 1